These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9510879)

  • 1. Effects of hormone replacement therapy on plasma glutathione S-transferase A1-1 concentrations in healthy postmenopausal women.
    Mulder TP; Knapen MF; van der Mooren MJ; Demacker PD; Roes EM; Steegers EA; Peters WH
    Clin Chem; 1998 Mar; 44(3):666-7. PubMed ID: 9510879
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
    Davidson MH; Maki KC; Marx P; Maki AC; Cyrowski MS; Nanavati N; Arce JC
    Arch Intern Med; 2000 Nov; 160(21):3315-25. PubMed ID: 11088095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial.
    Sanderson JE; Haines CJ; Yeung L; Yip GW; Tang K; Yim SF; Jorgensen LN; Woo J
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):372-83. PubMed ID: 11486242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
    Kaleli B; Yildirim B; Demir S; Alatas E
    Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
    Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
    Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activelle - modern low-dose hormone replacement therapy for postmenopausal women].
    Novo Nordisk.
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():28-30. PubMed ID: 11188014
    [No Abstract]   [Full Text] [Related]  

  • 8. Transdermal progestins in hormone replacement therapy.
    Jasonni VM; Naldi S; Amadori A; Santini D; Ceccarelli C; Possati G; D'Anna R; Leonardi J
    Ann N Y Acad Sci; 1997 Sep; 828():352-7. PubMed ID: 9329856
    [No Abstract]   [Full Text] [Related]  

  • 9. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
    Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
    Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
    Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J
    Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
    Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
    Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study.
    Madsen JS; Kristensen SR; Klitgaard NA; Bladbjerg EM; Abrahamsen B; Stilgren L; Jespersen J
    Am J Obstet Gynecol; 2002 Jul; 187(1):33-9. PubMed ID: 12114885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
    Agrawal R; Prelevic G; Conway GS; Payne NN; Ginsburg J; Jacobs HS
    Fertil Steril; 2000 Jan; 73(1):56-60. PubMed ID: 10632412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris.
    Haines CJ; Yim SF; Sanderson JE
    Atherosclerosis; 2001 Dec; 159(2):467-70. PubMed ID: 11730828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
    Christodoulakos G; Panoulis C; Kouskouni E; Chondros C; Dendrinos S; Creatsas G
    Gynecol Endocrinol; 2002 Feb; 16(1):9-17. PubMed ID: 11915588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.
    Salobir BG; Keber I; Vrabic L
    Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.